BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 37391712)

  • 1. Clinical characteristics of Leucine-rich glioma-inactivated protein 1 antibody-mediated autoimmune encephalitis in a 6-year-old girl: case report and literature reviews.
    Chen L; Su T; Liu Y
    BMC Neurol; 2023 Jun; 23(1):253. PubMed ID: 37391712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features of 28 cases of anti
    Feng J; Li J; Xie Y; Lü Y; Bi F; Zhou J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):386-396. PubMed ID: 37164922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure.
    Jang S; Kim SY; Kim WJ; Chae JH; Kim KJ; Lim BC
    Brain Dev; 2023 Jun; 45(6):348-353. PubMed ID: 36858863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.
    Huang X; Fan C; Gao L; Li L; Ye J; Shen H
    J Neuropsychiatry Clin Neurosci; 2022; 34(2):141-148. PubMed ID: 34794327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of anti-leucine-rich glioma-inactivated 1 encephalitis in northeast China.
    Zhao Q; Sun L; Zhao D; Chen Y; Li M; Lu Y; Li G; Lin W
    Clin Neurol Neurosurg; 2021 Apr; 203():106542. PubMed ID: 33706063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: Anti-IgLON5 disease and anti-LGI1 encephalitis following COVID-19.
    Li Y; Jia Y
    Front Immunol; 2023; 14():1195341. PubMed ID: 37383232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-brain metabolic pattern analysis in patients with anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis.
    Mo J; Dong W; Cui T; Chen C; Shi W; Hu W; Zhang C; Wang X; Zhang K; Shao X
    Eur J Neurol; 2022 Aug; 29(8):2376-2385. PubMed ID: 35514068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study.
    Muñoz-Lopetegi A; Guasp M; Prades L; Martínez-Hernández E; Rosa-Justícia M; Patricio V; Armangué T; Rami L; Borràs R; Castro-Fornieles J; Compte A; Gaig C; Santamaria J; Dalmau J;
    Lancet Neurol; 2024 Mar; 23(3):256-266. PubMed ID: 38365378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilomotor Seizures in a Patient With LGI1 Encephalitis.
    Yang J; Sun Q; Yang G
    Front Neurol; 2020; 11():61. PubMed ID: 32153488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-leucine-rich glioma inactivated protein 1 encephalitis with sleep disturbance as the first symptom: A case report and review of literature.
    Kong DL
    World J Clin Cases; 2023 Jan; 11(2):408-416. PubMed ID: 36686352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis of 9 cases with Anti-leucine-rich glioma inactivated 1 protein antibody associated limbic encephalitis].
    Zhang YX; Yang HL; Wu YY; Wang CC; Gao XY; Shi YY; Liu HQ; Huang Y; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2017 May; 97(17):1295-1298. PubMed ID: 28482428
    [No Abstract]   [Full Text] [Related]  

  • 12. Case Report: Paroxysmal weakness of unilateral limb as an initial symptom in anti-LGI1 encephalitis: a report of five cases.
    Wang S; Wang J; Li B; Hu N; Jin Y; Han S; Shang X
    Front Immunol; 2023; 14():1191823. PubMed ID: 37304289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faciobrachial Dystonic Seizures as a Sign of Relapse in a Child with LGI-1 Encephalitis.
    Alotaibi W; Bashir S; Mir A
    Child Neurol Open; 2022; 9():2329048X221105960. PubMed ID: 35677210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of patients with anti-leucine-rich glioma inactivated-1 protein associated encephalitis: a Chinese case series.
    Yang X; Li AN; Zhao XH; Liu XW; Wang SJ
    Int J Neurosci; 2019 Aug; 129(8):754-761. PubMed ID: 30621547
    [No Abstract]   [Full Text] [Related]  

  • 15. A rare case of antileucine-rich glioma-inactivated 1 encephalitis in a 14-year-old girl.
    Özçifçi G; Kamaşak T; Keskin DB
    Turk J Pediatr; 2022; 64(3):566-570. PubMed ID: 35899570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Leucine-rich glioma-inactivated Protein 1 antibody-associated encephalitis complicated by minimal change nephrotic syndrome: a case report.
    Zhang WJ; Gao N
    Eur Rev Med Pharmacol Sci; 2022 Oct; 26(20):7556-7560. PubMed ID: 36314326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-leucine-rich Glioma-inactivated-1 Encephalitis with Faciobrachial Dystonic Seizures and Behavioral Problems: A Case Report.
    Adhikari A; Subedi RC; Acharya S; Paudel R
    JNMA J Nepal Med Assoc; 2020 Jul; 58(227):487-490. PubMed ID: 32827010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study.
    Li W; Wu S; Meng Q; Zhang X; Guo Y; Cong L; Cong S; Zheng D
    BMC Neurol; 2018 Jul; 18(1):96. PubMed ID: 29980179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bi-Basal Ganglia Involvement with Signal Evolution in a Case of Anti-LGI1 Encephalitis.
    Gai Q; Ruan S; Dong X; Cong S
    Neurol India; 2022; 70(1):384-386. PubMed ID: 35263922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Features and Therapeutic Effects of Anti-leucine-rich Glioma Inactivated 1 Encephalitis: A Systematic Review.
    Teng Y; Li T; Yang Z; Su M; Ni J; Wei M; Shi J; Tian J
    Front Neurol; 2021; 12():791014. PubMed ID: 35095736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.